Is postoperative radioactive iodine associated with a survival advantage among…
Hamed Rasha Hamdy
Forum of Clinical Oncology · 2017
doi:10.1515/fco-2015-0027 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
This trial aimed to determine wether postoperative radioactive iodine(RAI) associated with a survival benefit among intermediate-risk Papillary Thyroid Cancer patients or not.
Abstract licence: CC BY-NC-ND
References16
16 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.